

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.19604632 |
| 2 | maturation of SSU-rRNA (GO:0030490) | 6.17484702 |
| 3 | chaperone-mediated protein transport (GO:0072321) | 6.15606201 |
| 4 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 6.01096796 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 5.90500889 |
| 6 | viral transcription (GO:0019083) | 5.81500247 |
| 7 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.68780213 |
| 8 | translational termination (GO:0006415) | 5.59585335 |
| 9 | respiratory electron transport chain (GO:0022904) | 5.26349130 |
| 10 | electron transport chain (GO:0022900) | 5.15891772 |
| 11 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.08046695 |
| 12 | cotranslational protein targeting to membrane (GO:0006613) | 5.03055451 |
| 13 | protein targeting to ER (GO:0045047) | 4.97015049 |
| 14 | ribosomal large subunit biogenesis (GO:0042273) | 4.79870631 |
| 15 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.77506587 |
| 16 | translational elongation (GO:0006414) | 4.77065707 |
| 17 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.71331163 |
| 18 | protein localization to endoplasmic reticulum (GO:0070972) | 4.68049455 |
| 19 | proteasome assembly (GO:0043248) | 4.59501210 |
| 20 | polyketide metabolic process (GO:0030638) | 4.54755116 |
| 21 | doxorubicin metabolic process (GO:0044598) | 4.54755116 |
| 22 | daunorubicin metabolic process (GO:0044597) | 4.54755116 |
| 23 | NADH dehydrogenase complex assembly (GO:0010257) | 4.42996568 |
| 24 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.42996568 |
| 25 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.42996568 |
| 26 | viral life cycle (GO:0019058) | 4.39300477 |
| 27 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.38709525 |
| 28 | termination of RNA polymerase III transcription (GO:0006386) | 4.38709525 |
| 29 | cellular protein complex disassembly (GO:0043624) | 4.32503265 |
| 30 | translational initiation (GO:0006413) | 4.29113158 |
| 31 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.28927086 |
| 32 | DNA deamination (GO:0045006) | 4.10095035 |
| 33 | respiratory chain complex IV assembly (GO:0008535) | 4.00917958 |
| 34 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.99819944 |
| 35 | establishment of integrated proviral latency (GO:0075713) | 3.98841377 |
| 36 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.92455626 |
| 37 | cytochrome complex assembly (GO:0017004) | 3.92208840 |
| 38 | translation (GO:0006412) | 3.86826477 |
| 39 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.83619145 |
| 40 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.74239200 |
| 41 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.74239200 |
| 42 | protein complex disassembly (GO:0043241) | 3.72301499 |
| 43 | protein targeting to mitochondrion (GO:0006626) | 3.65439574 |
| 44 | rRNA modification (GO:0000154) | 3.64228249 |
| 45 | CENP-A containing nucleosome assembly (GO:0034080) | 3.63437394 |
| 46 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.62285864 |
| 47 | chromatin remodeling at centromere (GO:0031055) | 3.59897647 |
| 48 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.59351426 |
| 49 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.59351426 |
| 50 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.58581382 |
| 51 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.56441602 |
| 52 | macromolecular complex disassembly (GO:0032984) | 3.54778300 |
| 53 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.50635736 |
| 54 | rRNA processing (GO:0006364) | 3.50179512 |
| 55 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.49823160 |
| 56 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.48017143 |
| 57 | inner mitochondrial membrane organization (GO:0007007) | 3.47632179 |
| 58 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.47257736 |
| 59 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.47030075 |
| 60 | DNA strand elongation (GO:0022616) | 3.46017526 |
| 61 | establishment of protein localization to mitochondrion (GO:0072655) | 3.44846500 |
| 62 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.44270808 |
| 63 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.44270808 |
| 64 | protein localization to mitochondrion (GO:0070585) | 3.44214373 |
| 65 | telomere maintenance via recombination (GO:0000722) | 3.43338617 |
| 66 | ATP biosynthetic process (GO:0006754) | 3.42848360 |
| 67 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.39248184 |
| 68 | cullin deneddylation (GO:0010388) | 3.38633310 |
| 69 | telomere maintenance via telomere lengthening (GO:0010833) | 3.37053037 |
| 70 | rRNA metabolic process (GO:0016072) | 3.36788153 |
| 71 | DNA double-strand break processing (GO:0000729) | 3.36654320 |
| 72 | * positive regulation of ligase activity (GO:0051351) | 3.34716560 |
| 73 | DNA damage response, detection of DNA damage (GO:0042769) | 3.34537309 |
| 74 | hydrogen ion transmembrane transport (GO:1902600) | 3.32188150 |
| 75 | spliceosomal snRNP assembly (GO:0000387) | 3.28272944 |
| 76 | 7-methylguanosine mRNA capping (GO:0006370) | 3.28191001 |
| 77 | 7-methylguanosine RNA capping (GO:0009452) | 3.27380377 |
| 78 | RNA capping (GO:0036260) | 3.27380377 |
| 79 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.26825933 |
| 80 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.26578717 |
| 81 | protein deneddylation (GO:0000338) | 3.26313001 |
| 82 | cellular component biogenesis (GO:0044085) | 3.26085819 |
| 83 | regulation of mitochondrial translation (GO:0070129) | 3.24158394 |
| 84 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.24132216 |
| 85 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.23306517 |
| 86 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.23306517 |
| 87 | mRNA catabolic process (GO:0006402) | 3.22982403 |
| 88 | intracellular protein transmembrane import (GO:0044743) | 3.21552768 |
| 89 | histone exchange (GO:0043486) | 3.21031309 |
| 90 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.20788925 |
| 91 | kinetochore assembly (GO:0051382) | 3.18544249 |
| 92 | termination of RNA polymerase I transcription (GO:0006363) | 3.18261343 |
| 93 | histone mRNA metabolic process (GO:0008334) | 3.18090601 |
| 94 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.17577927 |
| 95 | establishment of viral latency (GO:0019043) | 3.16079265 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.14815021 |
| 97 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.13907513 |
| 98 | mitotic recombination (GO:0006312) | 3.13765615 |
| 99 | kinetochore organization (GO:0051383) | 3.12657751 |
| 100 | DNA replication-independent nucleosome organization (GO:0034724) | 3.12633601 |
| 101 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.12633601 |
| 102 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.10334812 |
| 103 | DNA replication initiation (GO:0006270) | 3.07631653 |
| 104 | rRNA methylation (GO:0031167) | 3.06199359 |
| 105 | spliceosomal complex assembly (GO:0000245) | 3.05651117 |
| 106 | DNA ligation (GO:0006266) | 3.05338234 |
| 107 | transcription from RNA polymerase I promoter (GO:0006360) | 3.05037435 |
| 108 | pseudouridine synthesis (GO:0001522) | 3.04266537 |
| 109 | platelet dense granule organization (GO:0060155) | 3.04148236 |
| 110 | oxidative phosphorylation (GO:0006119) | 3.04009150 |
| 111 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.03110888 |
| 112 | viral mRNA export from host cell nucleus (GO:0046784) | 3.03098426 |
| 113 | RNA catabolic process (GO:0006401) | 3.02125303 |
| 114 | protein targeting to membrane (GO:0006612) | 3.01492229 |
| 115 | proton transport (GO:0015992) | 3.00637456 |
| 116 | * regulation of ligase activity (GO:0051340) | 2.99371112 |
| 117 | protein neddylation (GO:0045116) | 2.98880903 |
| 118 | mitochondrial transport (GO:0006839) | 2.97515993 |
| 119 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.95684090 |
| 120 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.94802906 |
| 121 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.92259074 |
| 122 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.91026813 |
| 123 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.90021541 |
| 124 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.89847758 |
| 125 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.89632190 |
| 126 | GTP biosynthetic process (GO:0006183) | 2.89307097 |
| 127 | DNA-templated transcription, termination (GO:0006353) | 2.87924495 |
| 128 | DNA replication checkpoint (GO:0000076) | 2.87814213 |
| 129 | regulation of DNA methylation (GO:0044030) | 2.87785461 |
| 130 | * negative regulation of ligase activity (GO:0051352) | 2.86280698 |
| 131 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.86280698 |
| 132 | ATP synthesis coupled proton transport (GO:0015986) | 2.85794763 |
| 133 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.85794763 |
| 134 | formation of translation preinitiation complex (GO:0001731) | 2.85729108 |
| 135 | protein complex biogenesis (GO:0070271) | 2.81777779 |
| 136 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.81676413 |
| 137 | ncRNA processing (GO:0034470) | 2.81459590 |
| 138 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78962516 |
| 139 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.78852131 |
| 140 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.78583663 |
| 141 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.78583663 |
| 142 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.78583663 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.29801126 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.62300105 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.31253923 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.19157638 |
| 5 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.91114962 |
| 6 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.83549309 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.41785646 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.34518690 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.32882691 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.24624360 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.05505051 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.91613018 |
| 13 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.85196832 |
| 14 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.84885482 |
| 15 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.81082777 |
| 16 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.79734713 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.77326643 |
| 18 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.68626840 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.61093916 |
| 20 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.59095107 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.41906852 |
| 22 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.41850404 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.41472837 |
| 24 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.38769364 |
| 25 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.34673987 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.27544098 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.24387445 |
| 28 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.17242388 |
| 29 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.15739004 |
| 30 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 2.14615693 |
| 31 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.12726492 |
| 32 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.10605532 |
| 33 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.09249239 |
| 34 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.09249239 |
| 35 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.09249239 |
| 36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.08578334 |
| 37 | * TTF2_22483619_ChIP-Seq_HELA_Human | 2.07273701 |
| 38 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.01970680 |
| 39 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.95991865 |
| 40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.94669603 |
| 41 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.87692412 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.83237148 |
| 43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.81098385 |
| 44 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80993051 |
| 45 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.80202582 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.77457408 |
| 47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.61190046 |
| 48 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.59523621 |
| 49 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59489149 |
| 50 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.55090598 |
| 51 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.54718129 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53844625 |
| 53 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.53777412 |
| 54 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.53070311 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52086212 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49539612 |
| 57 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.44623839 |
| 58 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.43227829 |
| 59 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43095882 |
| 60 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.39643240 |
| 61 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37791370 |
| 62 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37610124 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.31826874 |
| 64 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.31606638 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31114689 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.29053215 |
| 67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27996481 |
| 68 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.27369909 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.25498403 |
| 70 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24000619 |
| 71 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22890548 |
| 72 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.19283429 |
| 73 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18386210 |
| 74 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.18254754 |
| 75 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.15148115 |
| 76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13531395 |
| 77 | EWS_26573619_Chip-Seq_HEK293_Human | 1.13315532 |
| 78 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.12252002 |
| 79 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.10874787 |
| 80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09002707 |
| 81 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08887780 |
| 82 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.08258534 |
| 83 | VDR_22108803_ChIP-Seq_LS180_Human | 1.07466208 |
| 84 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.06573129 |
| 85 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06339251 |
| 86 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05141697 |
| 87 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02238814 |
| 88 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.01552931 |
| 89 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.00303764 |
| 90 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99185526 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97835776 |
| 92 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97707864 |
| 93 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.97384318 |
| 94 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94468340 |
| 95 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93503191 |
| 96 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.92848840 |
| 97 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.92770008 |
| 98 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.90190791 |
| 99 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89266178 |
| 100 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89266178 |
| 101 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.88960106 |
| 102 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85311541 |
| 103 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.85004375 |
| 104 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.84430945 |
| 105 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.84430945 |
| 106 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.83978592 |
| 107 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.83939275 |
| 108 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83876248 |
| 109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83505263 |
| 110 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.82351615 |
| 111 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.82191283 |
| 112 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.81889968 |
| 113 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81114298 |
| 114 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.79836768 |
| 115 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.78556068 |
| 116 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.76409684 |
| 117 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.75185218 |
| 118 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.74570909 |
| 119 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74031966 |
| 120 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.73682733 |
| 121 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.73442085 |
| 122 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.70142346 |
| 123 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.69340042 |
| 124 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.68568493 |
| 125 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.68065654 |
| 126 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.67945926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.37519891 |
| 2 | MP0008877_abnormal_DNA_methylation | 4.22588658 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.53577852 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.21417510 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.20245175 |
| 6 | MP0008058_abnormal_DNA_repair | 2.88804589 |
| 7 | MP0010094_abnormal_chromosome_stability | 2.82414414 |
| 8 | MP0005409_darkened_coat_color | 2.54909832 |
| 9 | MP0001188_hyperpigmentation | 2.49831771 |
| 10 | MP0000516_abnormal_urinary_system | 2.47143757 |
| 11 | MP0005367_renal/urinary_system_phenotyp | 2.47143757 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.41351354 |
| 13 | MP0000566_synostosis | 2.30254611 |
| 14 | MP0008057_abnormal_DNA_replication | 2.28053501 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.23015694 |
| 16 | MP0005670_abnormal_white_adipose | 2.21821170 |
| 17 | MP0002132_abnormal_respiratory_system | 2.21585533 |
| 18 | MP0003077_abnormal_cell_cycle | 2.21454294 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.15869325 |
| 20 | MP0008932_abnormal_embryonic_tissue | 2.11666477 |
| 21 | MP0002938_white_spotting | 1.98762976 |
| 22 | MP0002638_abnormal_pupillary_reflex | 1.96999516 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 1.96046234 |
| 24 | MP0004381_abnormal_hair_follicle | 1.94952516 |
| 25 | MP0002102_abnormal_ear_morphology | 1.91881791 |
| 26 | MP0005671_abnormal_response_to | 1.91770422 |
| 27 | MP0003195_calcinosis | 1.88233645 |
| 28 | MP0003136_yellow_coat_color | 1.82369455 |
| 29 | MP0005174_abnormal_tail_pigmentation | 1.77473936 |
| 30 | MP0008789_abnormal_olfactory_epithelium | 1.67767812 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.67131149 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.63547577 |
| 33 | MP0003123_paternal_imprinting | 1.55747283 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.55616812 |
| 35 | MP0002736_abnormal_nociception_after | 1.53159200 |
| 36 | MP0004133_heterotaxia | 1.48819118 |
| 37 | MP0000049_abnormal_middle_ear | 1.45336658 |
| 38 | MP0004147_increased_porphyrin_level | 1.39524172 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.37510876 |
| 40 | MP0003315_abnormal_perineum_morphology | 1.37171189 |
| 41 | MP0003786_premature_aging | 1.36000277 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.35280419 |
| 43 | MP0000015_abnormal_ear_pigmentation | 1.34258772 |
| 44 | MP0003567_abnormal_fetal_cardiomyocyte | 1.34118206 |
| 45 | MP0002095_abnormal_skin_pigmentation | 1.34081915 |
| 46 | MP0001835_abnormal_antigen_presentation | 1.31306668 |
| 47 | MP0003718_maternal_effect | 1.30675367 |
| 48 | MP0005171_absent_coat_pigmentation | 1.30391798 |
| 49 | MP0002148_abnormal_hypersensitivity_rea | 1.28217711 |
| 50 | MP0009785_altered_susceptibility_to | 1.28010456 |
| 51 | MP0002751_abnormal_autonomic_nervous | 1.26081024 |
| 52 | MP0005408_hypopigmentation | 1.23024685 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.22467090 |
| 54 | MP0002234_abnormal_pharynx_morphology | 1.21903939 |
| 55 | MP0001764_abnormal_homeostasis | 1.21700299 |
| 56 | MP0003878_abnormal_ear_physiology | 1.19289745 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 1.19289745 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.16864042 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.14490790 |
| 60 | MP0001286_abnormal_eye_development | 1.14099897 |
| 61 | MP0003938_abnormal_ear_development | 1.13324988 |
| 62 | MP0001905_abnormal_dopamine_level | 1.11897249 |
| 63 | MP0003941_abnormal_skin_development | 1.10942511 |
| 64 | MP0001485_abnormal_pinna_reflex | 1.10847844 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.08603965 |
| 66 | MP0005499_abnormal_olfactory_system | 1.08603965 |
| 67 | MP0008872_abnormal_physiological_respon | 1.08206195 |
| 68 | MP0000490_abnormal_crypts_of | 1.06510937 |
| 69 | MP0003724_increased_susceptibility_to | 1.06446122 |
| 70 | MP0003890_abnormal_embryonic-extraembry | 1.06425291 |
| 71 | MP0001293_anophthalmia | 1.04926521 |
| 72 | MP0000372_irregular_coat_pigmentation | 1.00962645 |
| 73 | MP0005551_abnormal_eye_electrophysiolog | 1.00509558 |
| 74 | MP0003937_abnormal_limbs/digits/tail_de | 0.99884339 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 0.97977397 |
| 76 | MP0005410_abnormal_fertilization | 0.97877154 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 0.97698038 |
| 78 | MP0003186_abnormal_redox_activity | 0.93123956 |
| 79 | MP0002233_abnormal_nose_morphology | 0.93121627 |
| 80 | MP0009250_abnormal_appendicular_skeleto | 0.92313271 |
| 81 | MP0006054_spinal_hemorrhage | 0.91778627 |
| 82 | MP0009697_abnormal_copulation | 0.90452751 |
| 83 | MP0001186_pigmentation_phenotype | 0.87986332 |
| 84 | MP0000762_abnormal_tongue_morphology | 0.87791594 |
| 85 | MP0002177_abnormal_outer_ear | 0.86316028 |
| 86 | MP0001919_abnormal_reproductive_system | 0.85170579 |
| 87 | MP0005645_abnormal_hypothalamus_physiol | 0.84972777 |
| 88 | MP0000613_abnormal_salivary_gland | 0.84774535 |
| 89 | MP0001929_abnormal_gametogenesis | 0.82502931 |
| 90 | MP0003763_abnormal_thymus_physiology | 0.82275193 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.81986985 |
| 92 | MP0005646_abnormal_pituitary_gland | 0.81851282 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.81695089 |
| 94 | MP0005389_reproductive_system_phenotype | 0.80057855 |
| 95 | MP0003011_delayed_dark_adaptation | 0.79053434 |
| 96 | MP0003806_abnormal_nucleotide_metabolis | 0.78728468 |
| 97 | MP0002090_abnormal_vision | 0.78395344 |
| 98 | MP0001529_abnormal_vocalization | 0.78388286 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.77643832 |
| 100 | MP0001853_heart_inflammation | 0.76988650 |
| 101 | MP0005395_other_phenotype | 0.76684338 |
| 102 | MP0000653_abnormal_sex_gland | 0.76645832 |
| 103 | MP0009333_abnormal_splenocyte_physiolog | 0.76568408 |
| 104 | MP0000313_abnormal_cell_death | 0.76192478 |
| 105 | MP0002254_reproductive_system_inflammat | 0.76101964 |
| 106 | MP0003787_abnormal_imprinting | 0.75853491 |
| 107 | MP0003121_genomic_imprinting | 0.74446479 |
| 108 | MP0005332_abnormal_amino_acid | 0.73913659 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.73716782 |
| 110 | MP0000350_abnormal_cell_proliferation | 0.73096490 |
| 111 | MP0000703_abnormal_thymus_morphology | 0.72547349 |
| 112 | MP0004142_abnormal_muscle_tone | 0.72255159 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.71787334 |
| 114 | MP0002282_abnormal_trachea_morphology | 0.71232434 |
| 115 | MP0005391_vision/eye_phenotype | 0.71177786 |
| 116 | MP0000358_abnormal_cell_content/ | 0.70523501 |
| 117 | MP0002210_abnormal_sex_determination | 0.70390301 |
| 118 | MP0000647_abnormal_sebaceous_gland | 0.69768650 |
| 119 | MP0006082_CNS_inflammation | 0.68587920 |
| 120 | MP0008873_increased_physiological_sensi | 0.67357704 |
| 121 | MP0002098_abnormal_vibrissa_morphology | 0.66880818 |
| 122 | MP0002160_abnormal_reproductive_system | 0.66683679 |
| 123 | MP0005253_abnormal_eye_physiology | 0.66576103 |
| 124 | MP0001145_abnormal_male_reproductive | 0.66417925 |
| 125 | MP0002697_abnormal_eye_size | 0.64550904 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.64228027 |
| 127 | MP0001873_stomach_inflammation | 0.64066895 |
| 128 | MP0000026_abnormal_inner_ear | 0.62477031 |
| 129 | MP0000569_abnormal_digit_pigmentation | 0.62158311 |
| 130 | MP0002163_abnormal_gland_morphology | 0.62051268 |
| 131 | MP0008995_early_reproductive_senescence | 0.61581204 |
| 132 | MP0004134_abnormal_chest_morphology | 0.61164381 |
| 133 | MP0002111_abnormal_tail_morphology | 0.60569862 |
| 134 | MP0002116_abnormal_craniofacial_bone | 0.59790942 |
| 135 | MP0002075_abnormal_coat/hair_pigmentati | 0.59604937 |
| 136 | MP0001346_abnormal_lacrimal_gland | 0.59392645 |
| 137 | MP0003385_abnormal_body_wall | 0.58615690 |
| 138 | MP0000631_abnormal_neuroendocrine_gland | 0.58513131 |
| 139 | MP0001119_abnormal_female_reproductive | 0.58222111 |
| 140 | MP0001984_abnormal_olfaction | 0.57632334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 4.87277747 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.81931355 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.60920348 |
| 4 | Cerebral edema (HP:0002181) | 4.08052897 |
| 5 | Macrocytic anemia (HP:0001972) | 3.82776677 |
| 6 | Increased intramyocellular lipid droplets (HP:0012240) | 3.49813153 |
| 7 | Cerebellar dysplasia (HP:0007033) | 3.41816872 |
| 8 | Pallor (HP:0000980) | 3.30930325 |
| 9 | Poor head control (HP:0002421) | 3.10506819 |
| 10 | Methylmalonic acidemia (HP:0002912) | 3.09686766 |
| 11 | Birth length less than 3rd percentile (HP:0003561) | 3.07753446 |
| 12 | 3-Methylglutaconic aciduria (HP:0003535) | 3.02818503 |
| 13 | Abnormality of the pons (HP:0007361) | 3.01985848 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 3.01600113 |
| 15 | Aplastic anemia (HP:0001915) | 3.00928044 |
| 16 | Lactic acidosis (HP:0003128) | 2.99181962 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 2.98535090 |
| 18 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.96121819 |
| 19 | Respiratory failure (HP:0002878) | 2.93314338 |
| 20 | Breast hypoplasia (HP:0003187) | 2.92808292 |
| 21 | Hypoplasia of the pons (HP:0012110) | 2.89462541 |
| 22 | Meckel diverticulum (HP:0002245) | 2.88196894 |
| 23 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.87934408 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 2.86161103 |
| 25 | Increased muscle lipid content (HP:0009058) | 2.83220442 |
| 26 | Microvesicular hepatic steatosis (HP:0001414) | 2.83017552 |
| 27 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.82633923 |
| 28 | Mitochondrial inheritance (HP:0001427) | 2.79152796 |
| 29 | Optic disc pallor (HP:0000543) | 2.77530188 |
| 30 | Severe visual impairment (HP:0001141) | 2.74566565 |
| 31 | Acute necrotizing encephalopathy (HP:0006965) | 2.74117571 |
| 32 | Leukodystrophy (HP:0002415) | 2.73732042 |
| 33 | Abnormality of the preputium (HP:0100587) | 2.73552510 |
| 34 | Abnormality of the ileum (HP:0001549) | 2.73093067 |
| 35 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.68919082 |
| 36 | Chromsome breakage (HP:0040012) | 2.67241638 |
| 37 | Methylmalonic aciduria (HP:0012120) | 2.66797190 |
| 38 | Triphalangeal thumb (HP:0001199) | 2.63524778 |
| 39 | Abnormality of renal resorption (HP:0011038) | 2.63301274 |
| 40 | Intestinal atresia (HP:0011100) | 2.62768991 |
| 41 | Respiratory difficulties (HP:0002880) | 2.57056925 |
| 42 | Lethargy (HP:0001254) | 2.55808702 |
| 43 | Type II lissencephaly (HP:0007260) | 2.54460732 |
| 44 | Lipid accumulation in hepatocytes (HP:0006561) | 2.50209657 |
| 45 | Hepatocellular necrosis (HP:0001404) | 2.48213142 |
| 46 | 11 pairs of ribs (HP:0000878) | 2.42784796 |
| 47 | Abnormality of midbrain morphology (HP:0002418) | 2.38782445 |
| 48 | Molar tooth sign on MRI (HP:0002419) | 2.38782445 |
| 49 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.37948720 |
| 50 | Pancreatic fibrosis (HP:0100732) | 2.34894303 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.33152219 |
| 52 | Abnormality of methionine metabolism (HP:0010901) | 2.32886456 |
| 53 | Abnormality of secondary sexual hair (HP:0009888) | 2.32105407 |
| 54 | Abnormality of the axillary hair (HP:0100134) | 2.32105407 |
| 55 | Duplicated collecting system (HP:0000081) | 2.31768032 |
| 56 | Septo-optic dysplasia (HP:0100842) | 2.30705971 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.29691180 |
| 58 | True hermaphroditism (HP:0010459) | 2.27865455 |
| 59 | Abnormality of chromosome stability (HP:0003220) | 2.26759768 |
| 60 | Abnormal lung lobation (HP:0002101) | 2.25713937 |
| 61 | Increased CSF lactate (HP:0002490) | 2.25580999 |
| 62 | Exertional dyspnea (HP:0002875) | 2.24504679 |
| 63 | Abnormality of urine glucose concentration (HP:0011016) | 2.20734402 |
| 64 | Glycosuria (HP:0003076) | 2.20734402 |
| 65 | Reduced antithrombin III activity (HP:0001976) | 2.20269913 |
| 66 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.19934878 |
| 67 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.19934878 |
| 68 | Calf muscle hypertrophy (HP:0008981) | 2.19803752 |
| 69 | Abnormality of the renal collecting system (HP:0004742) | 2.18653835 |
| 70 | Cerebral hypomyelination (HP:0006808) | 2.16546855 |
| 71 | Congenital, generalized hypertrichosis (HP:0004540) | 2.11442489 |
| 72 | Bone marrow hypocellularity (HP:0005528) | 2.09245086 |
| 73 | Hepatic necrosis (HP:0002605) | 2.09235418 |
| 74 | Progressive macrocephaly (HP:0004481) | 2.06785539 |
| 75 | Oral leukoplakia (HP:0002745) | 2.05503777 |
| 76 | Generalized aminoaciduria (HP:0002909) | 2.05498144 |
| 77 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.01415724 |
| 78 | Medial flaring of the eyebrow (HP:0010747) | 2.01258576 |
| 79 | Absent radius (HP:0003974) | 2.00722928 |
| 80 | Absent thumb (HP:0009777) | 2.00048171 |
| 81 | CNS demyelination (HP:0007305) | 1.99869043 |
| 82 | Duodenal stenosis (HP:0100867) | 1.99275648 |
| 83 | Small intestinal stenosis (HP:0012848) | 1.99275648 |
| 84 | Cleft eyelid (HP:0000625) | 1.98463980 |
| 85 | Nonprogressive disorder (HP:0003680) | 1.98221199 |
| 86 | Increased serum lactate (HP:0002151) | 1.97825936 |
| 87 | Stenosis of the external auditory canal (HP:0000402) | 1.97232450 |
| 88 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.96712155 |
| 89 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.96630117 |
| 90 | Abnormality of the duodenum (HP:0002246) | 1.96038253 |
| 91 | IgG deficiency (HP:0004315) | 1.96029255 |
| 92 | Hyperphosphaturia (HP:0003109) | 1.95208461 |
| 93 | Abnormal protein glycosylation (HP:0012346) | 1.94731131 |
| 94 | Abnormal glycosylation (HP:0012345) | 1.94731131 |
| 95 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.94731131 |
| 96 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.94731131 |
| 97 | Rough bone trabeculation (HP:0100670) | 1.94128076 |
| 98 | Acute encephalopathy (HP:0006846) | 1.93713875 |
| 99 | X-linked dominant inheritance (HP:0001423) | 1.93330742 |
| 100 | Supernumerary spleens (HP:0009799) | 1.90979911 |
| 101 | Absent forearm bone (HP:0003953) | 1.90899524 |
| 102 | Aplasia involving forearm bones (HP:0009822) | 1.90899524 |
| 103 | Myelodysplasia (HP:0002863) | 1.90483061 |
| 104 | Abnormality of vitamin B metabolism (HP:0004340) | 1.89646071 |
| 105 | Pendular nystagmus (HP:0012043) | 1.88476862 |
| 106 | Abnormality of placental membranes (HP:0011409) | 1.87995549 |
| 107 | Amniotic constriction ring (HP:0009775) | 1.87995549 |
| 108 | Nephronophthisis (HP:0000090) | 1.87729522 |
| 109 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.87202147 |
| 110 | Abnormality of the labia minora (HP:0012880) | 1.85672826 |
| 111 | Sparse eyelashes (HP:0000653) | 1.85505996 |
| 112 | Exercise intolerance (HP:0003546) | 1.84772668 |
| 113 | Medulloblastoma (HP:0002885) | 1.84705893 |
| 114 | Colon cancer (HP:0003003) | 1.84624931 |
| 115 | Hypoplasia of the radius (HP:0002984) | 1.84539169 |
| 116 | Premature graying of hair (HP:0002216) | 1.83296855 |
| 117 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.82954706 |
| 118 | Abnormality of serum amino acid levels (HP:0003112) | 1.82575431 |
| 119 | Megaloblastic anemia (HP:0001889) | 1.81340519 |
| 120 | Pancytopenia (HP:0001876) | 1.81335525 |
| 121 | Patellar aplasia (HP:0006443) | 1.80652332 |
| 122 | Shoulder girdle muscle weakness (HP:0003547) | 1.80268979 |
| 123 | Severe combined immunodeficiency (HP:0004430) | 1.79410334 |
| 124 | Hyperglycinemia (HP:0002154) | 1.76744495 |
| 125 | Absent septum pellucidum (HP:0001331) | 1.76432995 |
| 126 | Abnormal number of incisors (HP:0011064) | 1.76149946 |
| 127 | Renal hypoplasia (HP:0000089) | 1.76033518 |
| 128 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.75096708 |
| 129 | Progressive external ophthalmoplegia (HP:0000590) | 1.74765459 |
| 130 | Abnormality of eosinophils (HP:0001879) | 1.74523459 |
| 131 | Abnormal sex determination (HP:0012244) | 1.74115675 |
| 132 | Sex reversal (HP:0012245) | 1.74115675 |
| 133 | Cellular immunodeficiency (HP:0005374) | 1.73343321 |
| 134 | Horseshoe kidney (HP:0000085) | 1.73187506 |
| 135 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.73147849 |
| 136 | Dicarboxylic aciduria (HP:0003215) | 1.72807709 |
| 137 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.72807709 |
| 138 | Type 2 muscle fiber atrophy (HP:0003554) | 1.72495558 |
| 139 | Asplenia (HP:0001746) | 1.72415629 |
| 140 | Pancreatic cysts (HP:0001737) | 1.72188105 |
| 141 | Clubbing of toes (HP:0100760) | 1.72014414 |
| 142 | Parakeratosis (HP:0001036) | 1.70380393 |
| 143 | Sclerocornea (HP:0000647) | 1.68820501 |
| 144 | Blindness (HP:0000618) | 1.67772587 |
| 145 | Optic nerve hypoplasia (HP:0000609) | 1.66756980 |
| 146 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.65128802 |
| 147 | Congenital stationary night blindness (HP:0007642) | 1.65002510 |
| 148 | Abnormality of the fovea (HP:0000493) | 1.63588969 |
| 149 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.62645827 |
| 150 | Hypoplasia of the fovea (HP:0007750) | 1.62645827 |
| 151 | IgM deficiency (HP:0002850) | 1.61305595 |
| 152 | Increased serum pyruvate (HP:0003542) | 1.59335380 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 6.69908480 |
| 2 | VRK2 | 4.66557656 |
| 3 | BUB1 | 3.24591075 |
| 4 | SRPK1 | 2.96821407 |
| 5 | TLK1 | 2.77378558 |
| 6 | VRK1 | 2.73369533 |
| 7 | IRAK3 | 2.64971546 |
| 8 | BCKDK | 2.53806055 |
| 9 | PLK4 | 2.53120676 |
| 10 | MKNK1 | 2.30728200 |
| 11 | MKNK2 | 2.26687321 |
| 12 | NME2 | 2.25599706 |
| 13 | IRAK4 | 2.16013233 |
| 14 | CDK19 | 2.15129996 |
| 15 | EIF2AK1 | 2.06997964 |
| 16 | WNK3 | 1.97402360 |
| 17 | PBK | 1.91156774 |
| 18 | IRAK1 | 1.89103111 |
| 19 | ZAK | 1.87973948 |
| 20 | WEE1 | 1.87721093 |
| 21 | MAP4K2 | 1.77134817 |
| 22 | MAP3K12 | 1.68255776 |
| 23 | IRAK2 | 1.66127756 |
| 24 | CDC7 | 1.63892251 |
| 25 | EIF2AK3 | 1.55793713 |
| 26 | NEK1 | 1.45917403 |
| 27 | TRIM28 | 1.45049410 |
| 28 | TNIK | 1.42122761 |
| 29 | YES1 | 1.36640480 |
| 30 | DYRK3 | 1.35212174 |
| 31 | ACVR1B | 1.35039617 |
| 32 | BMPR1B | 1.33736810 |
| 33 | INSRR | 1.33489599 |
| 34 | KDR | 1.31251800 |
| 35 | NME1 | 1.25914567 |
| 36 | MST4 | 1.22641685 |
| 37 | RPS6KA4 | 1.22055602 |
| 38 | TAF1 | 1.19938076 |
| 39 | PASK | 1.16346982 |
| 40 | CDK7 | 1.09864524 |
| 41 | EIF2AK2 | 1.08511428 |
| 42 | TESK2 | 1.08245818 |
| 43 | RPS6KB2 | 1.06355985 |
| 44 | DYRK2 | 1.05435714 |
| 45 | PLK1 | 1.03800008 |
| 46 | TXK | 1.02633276 |
| 47 | AURKB | 1.01102969 |
| 48 | PLK3 | 0.99786972 |
| 49 | CLK1 | 0.96585807 |
| 50 | TAOK3 | 0.95267389 |
| 51 | TEC | 0.92398465 |
| 52 | TIE1 | 0.92386642 |
| 53 | PIM2 | 0.91396930 |
| 54 | TGFBR1 | 0.89595225 |
| 55 | TTK | 0.88682935 |
| 56 | TSSK6 | 0.86922836 |
| 57 | ATR | 0.86375190 |
| 58 | EPHA2 | 0.85600836 |
| 59 | CASK | 0.82620973 |
| 60 | MUSK | 0.81434810 |
| 61 | FRK | 0.81260939 |
| 62 | RPS6KA5 | 0.79508612 |
| 63 | PIK3CG | 0.79276309 |
| 64 | NLK | 0.78862224 |
| 65 | CDK8 | 0.78031612 |
| 66 | STK4 | 0.71447756 |
| 67 | BRD4 | 0.71354450 |
| 68 | LYN | 0.70977399 |
| 69 | PDK2 | 0.67947232 |
| 70 | GRK1 | 0.67395395 |
| 71 | CSNK2A1 | 0.66234437 |
| 72 | BTK | 0.65449685 |
| 73 | CHEK2 | 0.64657148 |
| 74 | AURKA | 0.64209708 |
| 75 | MYLK | 0.59406905 |
| 76 | BCR | 0.59312680 |
| 77 | CSNK1G2 | 0.59136475 |
| 78 | NUAK1 | 0.58683202 |
| 79 | CDK3 | 0.58333030 |
| 80 | CSNK2A2 | 0.57692157 |
| 81 | STK38L | 0.54834714 |
| 82 | PRKCI | 0.54555846 |
| 83 | MAP2K7 | 0.53457702 |
| 84 | ERBB3 | 0.53024813 |
| 85 | DAPK1 | 0.52693359 |
| 86 | CHEK1 | 0.51645681 |
| 87 | CSNK1G3 | 0.50595909 |
| 88 | PNCK | 0.50097683 |
| 89 | FLT3 | 0.50010917 |
| 90 | ABL2 | 0.48702492 |
| 91 | BRSK1 | 0.47345060 |
| 92 | OXSR1 | 0.47065768 |
| 93 | IKBKB | 0.47013232 |
| 94 | ILK | 0.46712587 |
| 95 | MATK | 0.45686186 |
| 96 | BRSK2 | 0.45451206 |
| 97 | ATM | 0.45035528 |
| 98 | KIT | 0.43078281 |
| 99 | PRKCG | 0.42184844 |
| 100 | MAPK13 | 0.41119047 |
| 101 | PRKCE | 0.40441619 |
| 102 | CSNK1G1 | 0.40352033 |
| 103 | MAP3K4 | 0.40317372 |
| 104 | MARK1 | 0.39979880 |
| 105 | ABL1 | 0.39787416 |
| 106 | NEK6 | 0.39756129 |
| 107 | GRK7 | 0.39596478 |
| 108 | BLK | 0.37124670 |
| 109 | PIM1 | 0.35458539 |
| 110 | EPHB2 | 0.34869723 |
| 111 | GRK5 | 0.34781258 |
| 112 | PAK4 | 0.33837275 |
| 113 | CDK2 | 0.33643960 |
| 114 | CDK1 | 0.32923576 |
| 115 | PRKCQ | 0.32423966 |
| 116 | CSNK1A1L | 0.32384392 |
| 117 | STK10 | 0.32062361 |
| 118 | CCNB1 | 0.31803848 |
| 119 | STK3 | 0.31800700 |
| 120 | MAP2K6 | 0.30793398 |
| 121 | CSNK1A1 | 0.30448049 |
| 122 | ADRBK1 | 0.30403860 |
| 123 | ADRBK2 | 0.29947217 |
| 124 | STK39 | 0.29300252 |
| 125 | FGFR1 | 0.27934907 |
| 126 | PLK2 | 0.27455149 |
| 127 | BMPR2 | 0.27329672 |
| 128 | CDK9 | 0.26999497 |
| 129 | TRPM7 | 0.26894265 |
| 130 | MAPK15 | 0.26364109 |
| 131 | LCK | 0.25729424 |
| 132 | OBSCN | 0.25312173 |
| 133 | MAP4K1 | 0.23723553 |
| 134 | AKT3 | 0.23677576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.37081221 |
| 2 | RNA polymerase_Homo sapiens_hsa03020 | 3.97037894 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.93044252 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 3.61787176 |
| 5 | Homologous recombination_Homo sapiens_hsa03440 | 3.45099462 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.43169318 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 3.20170555 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.93022171 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.65306136 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.44217696 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.40171578 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.36859949 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.13762557 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.12188037 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.05117653 |
| 16 | Basal transcription factors_Homo sapiens_hsa03022 | 2.03998231 |
| 17 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.91868575 |
| 18 | RNA transport_Homo sapiens_hsa03013 | 1.90001986 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.81211598 |
| 20 | RNA degradation_Homo sapiens_hsa03018 | 1.74103322 |
| 21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.69413731 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.58850173 |
| 23 | Purine metabolism_Homo sapiens_hsa00230 | 1.53793637 |
| 24 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.51271808 |
| 25 | * Cell cycle_Homo sapiens_hsa04110 | 1.41746133 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.38983750 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36397453 |
| 28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.22962732 |
| 29 | Alzheimers disease_Homo sapiens_hsa05010 | 1.12330483 |
| 30 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.04011670 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97314413 |
| 32 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.96685671 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.94374400 |
| 34 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93266501 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.92587496 |
| 36 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.87052613 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86161801 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81383925 |
| 39 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.81074248 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80377020 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.79786201 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79627224 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78434435 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77649094 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 0.77466086 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77272150 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76620647 |
| 48 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75622824 |
| 49 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69618559 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68274940 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67948136 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67430142 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66847437 |
| 54 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.66382989 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.65979859 |
| 56 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.64606647 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.62544038 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61179577 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60922061 |
| 60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58411265 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56431822 |
| 62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55405989 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54918042 |
| 64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54917884 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.52444130 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50828539 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49368988 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49305856 |
| 69 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48942701 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48124648 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46856539 |
| 72 | Asthma_Homo sapiens_hsa05310 | 0.46212791 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44264091 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.44163055 |
| 75 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.43921063 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43880726 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43220333 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41022397 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.40028284 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39299852 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37537137 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37379561 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36850568 |
| 84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.36748471 |
| 85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.35938124 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35296525 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.34704231 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33771910 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33433148 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.32031983 |
| 91 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31807005 |
| 92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.31699509 |
| 93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30855428 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30820492 |
| 95 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30274006 |
| 96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29028644 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.28203249 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.27882868 |
| 99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27165009 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26768881 |
| 101 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26749594 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.26312059 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25512961 |
| 104 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24589227 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24529182 |
| 106 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.24393503 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.24329111 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.24252890 |
| 109 | Retinol metabolism_Homo sapiens_hsa00830 | 0.23138921 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23068028 |
| 111 | Carbon metabolism_Homo sapiens_hsa01200 | 0.21720641 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21518306 |
| 113 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.21083562 |
| 114 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.19861190 |
| 115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19602527 |
| 116 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.18926037 |
| 117 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.18756788 |
| 118 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.18593171 |
| 119 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.17850993 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.17255338 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.17079266 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.16984668 |
| 123 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.16969074 |
| 124 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.16650162 |
| 125 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.15663417 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.14783363 |
| 127 | Histidine metabolism_Homo sapiens_hsa00340 | 0.14336622 |

